IDH2 and glioblastoma: DNA methylation profiling of CSF of patients with IDH-WT glioblastoma, and IDH-mutant diffuse gliomas, as well as non-neoplastic controls, was performed using cell-free methylated DNA immunoprecipitation and high-throughput sequencing (cfMeDIP-seq).